Reply: Is high-dose glucocorticoid beneficial in COVID-19?

Our clinical trial supports the beneficial use of a high dose of methylprednisolone for the treatment of severe COVID-19 patients. https://bit.ly/3qvc4Kz

Detalles Bibliográficos
Autores principales: Edalatifard, Maryam, Akhtari, Maryam, Salehi, Mohammadreza, Farhadi, Elham, Jamshidi, Ahmadreza, Mahmoudi, Mahdi, Rostamian, Abdolrahman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898159/
https://www.ncbi.nlm.nih.gov/pubmed/33602862
http://dx.doi.org/10.1183/13993003.00324-2021
_version_ 1783653809540562944
author Edalatifard, Maryam
Akhtari, Maryam
Salehi, Mohammadreza
Farhadi, Elham
Jamshidi, Ahmadreza
Mahmoudi, Mahdi
Rostamian, Abdolrahman
author_facet Edalatifard, Maryam
Akhtari, Maryam
Salehi, Mohammadreza
Farhadi, Elham
Jamshidi, Ahmadreza
Mahmoudi, Mahdi
Rostamian, Abdolrahman
author_sort Edalatifard, Maryam
collection PubMed
description Our clinical trial supports the beneficial use of a high dose of methylprednisolone for the treatment of severe COVID-19 patients. https://bit.ly/3qvc4Kz
format Online
Article
Text
id pubmed-7898159
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-78981592021-02-23 Reply: Is high-dose glucocorticoid beneficial in COVID-19? Edalatifard, Maryam Akhtari, Maryam Salehi, Mohammadreza Farhadi, Elham Jamshidi, Ahmadreza Mahmoudi, Mahdi Rostamian, Abdolrahman Eur Respir J Agora Our clinical trial supports the beneficial use of a high dose of methylprednisolone for the treatment of severe COVID-19 patients. https://bit.ly/3qvc4Kz European Respiratory Society 2021-04-15 /pmc/articles/PMC7898159/ /pubmed/33602862 http://dx.doi.org/10.1183/13993003.00324-2021 Text en Copyright ©The authors 2021. https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org)
spellingShingle Agora
Edalatifard, Maryam
Akhtari, Maryam
Salehi, Mohammadreza
Farhadi, Elham
Jamshidi, Ahmadreza
Mahmoudi, Mahdi
Rostamian, Abdolrahman
Reply: Is high-dose glucocorticoid beneficial in COVID-19?
title Reply: Is high-dose glucocorticoid beneficial in COVID-19?
title_full Reply: Is high-dose glucocorticoid beneficial in COVID-19?
title_fullStr Reply: Is high-dose glucocorticoid beneficial in COVID-19?
title_full_unstemmed Reply: Is high-dose glucocorticoid beneficial in COVID-19?
title_short Reply: Is high-dose glucocorticoid beneficial in COVID-19?
title_sort reply: is high-dose glucocorticoid beneficial in covid-19?
topic Agora
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898159/
https://www.ncbi.nlm.nih.gov/pubmed/33602862
http://dx.doi.org/10.1183/13993003.00324-2021
work_keys_str_mv AT edalatifardmaryam replyishighdoseglucocorticoidbeneficialincovid19
AT akhtarimaryam replyishighdoseglucocorticoidbeneficialincovid19
AT salehimohammadreza replyishighdoseglucocorticoidbeneficialincovid19
AT farhadielham replyishighdoseglucocorticoidbeneficialincovid19
AT jamshidiahmadreza replyishighdoseglucocorticoidbeneficialincovid19
AT mahmoudimahdi replyishighdoseglucocorticoidbeneficialincovid19
AT rostamianabdolrahman replyishighdoseglucocorticoidbeneficialincovid19

Ejemplares similares